X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WYETH LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WYETH LTD ABBOTT INDIA/
WYETH LTD
 
P/E (TTM) x 42.5 27.7 153.5% View Chart
P/BV x 10.6 5.3 198.6% View Chart
Dividend Yield % 0.6 1.3 49.6%  

Financials

 ABBOTT INDIA   WYETH LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
WYETH LTD
Mar-13
ABBOTT INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,044 575.9%   
Low Rs3,707818 453.2%   
Sales per share (Unadj.) Rs1,236.9298.6 414.3%  
Earnings per share (Unadj.) Rs122.257.2 213.4%  
Cash flow per share (Unadj.) Rs129.058.4 220.8%  
Dividends per share (Unadj.) Rs35.0017.00 205.9%  
Dividend yield (eoy) %0.71.8 39.4%  
Book value per share (Unadj.) Rs521.2249.5 208.9%  
Shares outstanding (eoy) m21.2522.72 93.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.93.1 126.0%   
Avg P/E ratio x39.816.3 244.6%  
P/CF ratio (eoy) x37.715.9 236.4%  
Price / Book Value ratio x9.33.7 249.8%  
Dividend payout %28.629.7 96.5%   
Avg Mkt Cap Rs m103,29621,157 488.2%   
No. of employees `0003.00.5 600.8%   
Total wages/salary Rs m3,370400 842.5%   
Avg. sales/employee Rs Th8,891.813,787.4 64.5%   
Avg. wages/employee Rs Th1,140.0813.0 140.2%   
Avg. net profit/employee Rs Th878.32,643.3 33.2%   
INCOME DATA
Net Sales Rs m26,2846,783 387.5%  
Other income Rs m504353 143.1%   
Total revenues Rs m26,7897,136 375.4%   
Gross profit Rs m3,6651,617 226.6%  
Depreciation Rs m14427 542.9%   
Interest Rs m86 147.3%   
Profit before tax Rs m4,0171,938 207.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,421632 224.8%   
Profit after tax Rs m2,5961,301 199.6%  
Gross profit margin %13.923.8 58.5%  
Effective tax rate %35.432.6 108.4%   
Net profit margin %9.919.2 51.5%  
BALANCE SHEET DATA
Current assets Rs m14,4466,984 206.9%   
Current liabilities Rs m4,7252,056 229.8%   
Net working cap to sales %37.072.6 50.9%  
Current ratio x3.13.4 90.0%  
Inventory Days Days5199 51.8%  
Debtors Days Days2024 81.7%  
Net fixed assets Rs m1,113244 455.5%   
Share capital Rs m213227 93.5%   
"Free" reserves Rs m10,8085,441 198.6%   
Net worth Rs m11,0765,668 195.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m16,2417,901 205.6%  
Interest coverage x497.0353.3 140.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.9 188.5%   
Return on assets %16.016.5 97.0%  
Return on equity %23.422.9 102.2%  
Return on capital %36.334.0 106.7%  
Exports to sales %0.60.2 281.8%   
Imports to sales %12.636.3 34.8%   
Exports (fob) Rs m16215 1,091.9%   
Imports (cif) Rs m3,3222,465 134.8%   
Fx inflow Rs m26815 1,763.2%   
Fx outflow Rs m3,9272,677 146.7%   
Net fx Rs m-3,659-2,662 137.5%   
CASH FLOW
From Operations Rs m2,514923 272.3%  
From Investments Rs m-800317 -252.3%  
From Financial Activity Rs m-803-481 166.9%  
Net Cashflow Rs m912759 120.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 7.2 1.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 30.4 56.3%  
Shareholders   18,270 21,978 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 16, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS